Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Recruiting now
Conditions studied: Stargardt Disease, Stargardt Disease 1, Cone Rod Dystrophy, Juvenile Macular Degeneration
In brief
This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
Key facts
- Study ID
- NCT06445322
- Run by
- Ascidian Therapeutics, Inc
- People needed
- 50
- Starts
- 2024-06-20
- Expected to finish
- 2030-08-31
- Last updated by the study team
- 2026-03-11
Who can join
Age: 5 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of San Francisco — San Francisco, California, United States (enrolling)
- Vitreo Retinal Associates — Gainesville, Florida, United States (enrolling)
- Wilmer Eye Institute at John Hopkins — Baltimore, Maryland, United States (enrolling)
- Massachusetts Eye and Ear — Boston, Massachusetts, United States (enrolling)
- University of Michigan Kellogg Eye Center — Ann Arbor, Michigan, United States (enrolling)
- Cincinnati Eye Institute — Cincinnati, Ohio, United States (enrolling)
- Retina Foundation of Texas — Dallas, Texas, United States (enrolling)
- Retina Consultants of Texas — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.